• Illumina, Genetic Alliance Launch iHope Genetic Health for Whole Genome Sequencing

    Nov 22 | Diagnostics World | Illumina and Genetic Alliance announced this week the creation of the iHope Genetic Health program aimed at providing whole-genome sequencing access (WGS) to tens of thousands of patients across the globe impacted by genetic disease. At least half of iHope Genetic Health's efforts will be focused on areas of the world in need outside the US, with more than one-third of Illumina's support being dedicated to patients in Africa. More

  • New Virus Panel Detects Coinfections—And Could Inform Development Of COVID Boosters

    Nov 17 | Diagnostics World News | Labs around the country with next-generation sequencing capabilities have begun using a respiratory virus panel that simultaneously tests for SARS-CoV-2 and 40 other potentially co-occurring respiratory viruses, including four cold-causing coronaviruses, both types of respiratory syncytial viruses (RSV), and more than a dozen influenza viruses. More

  • Geisinger Looks to Develop Tool for Genetic Disorders, Shorten Diagnostic Odysseys

    Nov 15 | Diagnostics World News| Geisinger researchers have been awarded a $5 million grant to develop a diagnostic tool for genetic disorders. With support from the National Institutes of Health’s National Human Genome Research Institute, the group plans to build a High Impact Phenotype Identification System. The aim is to trim the time between symptom onset and the discovery of a genetic basis to improve patient care and outcomes. More

  • Rapid Test For Alzheimer’s Disease Risk Begins Human Testing Next Year

    Nov 15 | Diagnostics World News | Researchers in Germany are developing a lateral flow assay that aims to inform people if they are at heightened risk of developing Alzheimer’s disease (AD) and the robustness of their “cognitive reserve” to stave off symptoms of degenerative brain changes—all by measuring levels of three microRNAs (miRNAs) circulating in their blood. More

  • Genomics England Reports Results on Clinical Use of Whole Genome Sequencing

    Nov 11 | Diagnostics World News | The U.K. 100,000 Genomes Project published the results of a pilot study seeking diagnoses for 4,660 participants from 2,183 families with rare diseases. They found that whole genome sequencing measurably improved diagnoses for patients with a wide range of genetic illnesses and saved money for the healthcare system. More

  • Cardiac MRI Best For Diagnosing Growing Incidence Of ‘Broken Heart’ Syndrome

    Nov 10 | Diagnostics World News | Rising incidence of takotsubo or “broken heart” syndrome is highlighting the need to better differentiate the condition from myocardial infarctions involving blocked arteries as well as other types of myocardial infarction with non-obstructive coronary arteries (MINOCA)—and to figure out the root causes. The best that can be done for patients currently is to as quickly as possible get detailed pictures of their heart from cardiac magnetic resonance (CMR) imaging to improve the odds that they’ll be properly diagnosed and treated. More

  • New Diagnostic Technique Measures Nanoparticles Linked To Lupus

    Nov 04 | Diagnostics World News | Researchers in Denmark are pursuing development of a diagnostic approach pairing a liquid biopsy test with nanoparticle tracking analysis to measure disease severity in patients with autoimmune diseases. While at least five years away from making an appearance in hospital labs, their patented Nanoscale Immunoactive Protein Quantification (NIP-Q) technique has already been used to discover patients with systemic lupus erythematosus (SLE) have a higher concentration of certain DNA–protein complexes in their blood. More

  • AMP Members Call For Better Future Pandemic Diagnostic Preparedness

    Nov 03 | Diagnostics World News | In a new article published in JAMA Health Forum last week, members of the Association for Molecular Pathology COVID Response Steering Committee offered recommendations to improve the US’s ability to respond to the current COVID-19 pandemic and prepare for future emerging infectious disease outbreaks. More

  • Follow the Money: COVID Diagnostic Supplies, Single Cell Analysis

    Nov 02 | Diagnostics World News | New public biotech fund, single cell analysis system, Air Force investment in diagnostic reagents, and more. More

  • Molecular Health, DNAe Both Launch Collaborations on Personalized Treatment for Cancer, More

    Oct 29 | Diagnostics World News | Roche and Ibex Medical Analytics launch AI pathology agreement, University of Warwick and Iceni Diagnostics take a new look at SARS-CoV-2 testing, Caris Life Sciences and Ono Pharma collaborate on liquid biopsy, and wearables for cardiac health. Plus new products from MIP Diagnostics, AliveCor, Bio-Rad, and more. More
View more articles

 
DXX-Industry-spotlight

Acrobiosystems

Antigens & Antibodies for SARS-CoV-2 Diagnostic Kit Development

ACROBiosystems team has worked tirelessly since the genomic sequence of SARS-CoV-2 was first published, developing a serial of high-quality antigen and antibody reagents to support the development of the diagnostic kits. The products include the high quality S trimer, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity tested on several platforms.

Click to learn more about ACRO’s hot matched antibody pairs and antigens.